SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities
SEC Accession No. 0001179110-12-015669
Filing Date
2012-11-05
Accepted
2012-11-05 13:04:10
Documents
1
Period of Report
2012-11-01
Filing Date Changed
2012-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2237
  Complete submission text file 0001179110-12-015669.txt   3631
Mailing Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address MORRIS CORPORATE CENTER III 400 INTERPACE PARKWAY PARSIPPANY NJ 07054 9092701400
WATSON PHARMACEUTICALS INC (Issuer) CIK: 0000884629 (see all company filings)

IRS No.: 953872914 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address 400 INTERPACE PARKWAY PARSIPPANY NJ 07054
Business Address
Fridriksdottir Hafrun (Reporting) CIK: 0001561458 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13305 | Film No.: 121179319